September 12, 2023 A new article, describing a set of affibody-based NK cell engagers using B cell maturation antigen as a model antigen for targeting of.
STOCKHOLM, Sept. 7, 2022 /PRNewswire/ Oncopeptides AB (publ) (Nasdaq: ONCO) (Stockholm: ONCO), a biotech company focused on research and development of therapies for difficult-to-treat hematological